Key facts
- This page summarizes Mandar Ranade's Form 4 filing for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Jun 2023, 12:35.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
This amount includes 1,005 additional shares that were received upon settlement of the performance-based Restricted Stock Units, originally granted on June 23, 2020, as a result of the performance component of the grant vesting at 125% on June 23, 2023.
Footnote F2
Restricted stock units convert to common stock on a one-for-one basis.
Footnote F3
On June 23, 2020, the reporting person was granted restricted stock units that vest as follows: (a) 40% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 23, 2021, subject to the reporting person's continued employment with the Company, and (b) 60% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.